高齢患者における周術期神経認知障害の管理:過去、現在、未来
Sarah Saxena1,2, Yotam Weiss3, Thomas Saller4
1Department of Surgery, Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium. sarahksaxena@gmail.com.
BMC anesthesiology
|December 28, 2025
まとめ
周術期神経認知障害は高齢者にとって困難な問題です。これらの複雑な状態を効果的に管理するためのギャップを埋めるには、より大規模な研究が必要です。
科学分野:
- 麻酔科学
- 老年医学
- 神経科学
背景:
- 神経認知障害(NCD)は、特に高齢患者において、周術期に重大な課題をもたらします。
- スクリーニングやケアバンドルの進歩にもかかわらず、NCD管理における知識と実施のギャップが残っています。
- 周術期は、高齢者の認知機能低下に特有のリスクをもたらします。
研究 の 目的:
- 高齢者集団における周術期神経認知障害の管理における継続的な課題を強調すること。
- 現在理解および臨床実践におけるギャップに対処する堅牢な研究の必要性を強調すること。
- 高齢者の手術患者におけるNCD管理のための改善された戦略の開発と実施を奨励すること。
主な方法:
- このセクションでは、研究の必要性に焦点を当てており、具体的な実験方法については詳述していません。
- 要旨では、大規模で質の高い研究の必要性を強調しています。
- 周術期NCDケアにおける知識と実施の両方の欠点を対処する研究を求めています。
主要な成果:
- 神経認知障害は、周術期において持続的な合併症として特定されています。
- 既存のスクリーニングツールやケアバンドルでは、この問題は完全には解決されていません。
- NCD管理戦略の知識と実践の両方に、認識されているギャップが存在します。
結論:
- 高齢患者における周術期神経認知障害の管理は、依然として複雑な臨床問題です。
- この分野を進歩させるためには、さらなる大規模で質の高い研究が不可欠です。
- 患者の転帰を改善するためには、既存の知識と実施のギャップに対処することが不可欠です。
さらに関連する動画
関連する概念動画
Pharmacodynamics in Geriatric Patients: Effects of Age
174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
205
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
205
Peripheral Artery Disease V: Postoperative Nursing Management
347
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
347
Cardiomyopathy VII: Pre and Post Operative Nursing Management
251
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
251
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
178
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
178


